# Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares

> **NCT01120340** · PHASE3 · COMPLETED · sponsor: **SOFAR S.p.A.** · enrollment: 105 (actual)

## Conditions studied

- Diverticular Disease

## Interventions

- **DRUG:** mesalamine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01120340
- **Lead sponsor:** SOFAR S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120340, "Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01120340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*